Catheter Precision Files 8-K

TL;DR

CATHERINE PRECISION (CPTR) FILED A STANDARD 8-K. NO MAJOR NEWS.

AI Summary

Catheter Precision, Inc. filed an 8-K on August 18, 2025, reporting other events and financial statements. The company, formerly known as Ra Medical Systems, Inc., is incorporated in Delaware and headquartered in Fort Mill, SC. The filing does not disclose specific financial transactions or material events beyond the standard reporting requirements.

Why It Matters

This 8-K filing indicates routine corporate reporting by Catheter Precision, Inc. It does not appear to contain any new material information that would immediately impact the company's stock.

Risk Assessment

Risk Level: low — The filing is a routine 8-K report and does not disclose any new material events or financial information that would inherently increase risk.

Key Numbers

• 001-38677 — SEC File Number (Identifies the company's filing with the SEC.)
• 38-3661826 — IRS Employer Identification No. (Company's tax identification number.)

Key Players & Entities

• Catheter Precision, Inc. (company) — Registrant
• Ra Medical Systems, Inc. (company) — Former company name
• August 18, 2025 (date) — Date of earliest event reported
• Delaware (jurisdiction) — State of incorporation
• Fort Mill, SC (location) — Principal executive offices location

FAQ

Key Financial Figures

• $0.0001 — ch registered Common Stock , par value $0.0001 per share VTAK NYSE American Indica

Filing Documents

• vtak20250818c_8k.htm (8-K) — 37KB
• ex_854469.htm (EX-5.1) — 9KB
• ex_854595.htm (EX-99.1) — 9KB
• aggllp.jpg (GRAPHIC) — 4KB
• logo.jpg (GRAPHIC) — 4KB
• logosml.jpg (GRAPHIC) — 3KB
• sig.jpg (GRAPHIC) — 3KB
• 0001437749-25-027270.txt ( ) — 217KB
• vtak-20250818.xsd (EX-101.SCH) — 3KB
• vtak-20250818_def.xml (EX-101.DEF) — 12KB
• vtak-20250818_lab.xml (EX-101.LAB) — 15KB
• vtak-20250818_pre.xml (EX-101.PRE) — 12KB
• vtak20250818c_8k_htm.xml (XML) — 3KB

01 Other Events

Item 8.01 Other Events. This Form 8-K is being filed for the purpose of filing the legal opinion of Arnall Golden Gregory LLP dated August 18, 2025 in connection with the Prospectus Supplement dated August 7, 2025 of Catheter Precision, Inc. (the "Company"), in order that it may be incorporated by reference into the Company's Registration Statement on Form S-3 (Registration No. 333-284217). Also, the Company issued a press release on August 18, 2025 regarding approval of its LockeT product in Great Britain. A copy of the press release is attached as Exhibit 99.1 hereto and is incorporated by reference herein. Forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are contained in the press release include that LockeT enhances patient comfort and recovery and enables earlier patient discharge following cardiac procedures and that LockeT helps clinicians deliver more treatments, more efficiently. Risks that could cause the forward-looking statements in the press release not to occur as expected, and other general business risks impacting our business, include the following: there is no guarantee that future LockeT use will generate all of the benefits seen to date, competition in the wound closure space is intense, and many of our competitors are better capitalized than we are, even if they see the benefits of LockeT, hospitals could choose competing products for economic reasons, we will be required to raise additional funds to finance our operations and continue as a going concern, and we may not be able to do so when necessary, and/or the terms of any financings may not be advantageous to us, and we may require additional funds sooner than our current expectations; our business has a history of losses, will incur additional losses, and may never achieve profitability; we have identified material weaknesses in our internal control over financial reporting and these material weaknesses could adversely affect our

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Description 5.1 Opinion Letter of Arnall Golden Gregory LLP dated August 18, 2025 99.1 Press Release Dated August 18, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CATHETER PRECISION, INC. Date: August 18, 2025 By: /s/ Philip Anderson Philip Anderson Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR